Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

26.7%

4 terminated/withdrawn out of 15 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

70%

7 of 10 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

Phase 2

5(33.3%)

Phase 1

4(26.7%)

Phase 3

4(26.7%)

Phase 4

1(6.7%)

N/A

1(6.7%)

15Total

Phase 2(5)

Phase 1(4)

Phase 3(4)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT06436911Phase 1Completed

To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

Role: collaborator

NCT05188729Phase 2Completed

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Role: collaborator

NCT05927649Phase 1Completed

A TQTc Study for Omaveloxolone

Role: collaborator

NCT05909644Phase 1Completed

An Open-label DDI Study of Omaveloxolone in Healthy Subjects

Role: collaborator

NCT05561764Phase 4Terminated

Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Role: collaborator

NCT05003310Not ApplicableRecruiting

ConsideRAte Study - Splenic Stimulation for RA

Role: collaborator

NCT04731298Phase 2Terminated

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

Role: collaborator

NCT06125717Phase 1Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Role: collaborator

NCT01593254Phase 2Completed

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Role: collaborator

NCT02349386Phase 2Terminated

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Role: collaborator

NCT02725593Phase 3Completed

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Role: collaborator

NCT03029247Phase 2Completed

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Role: collaborator

NCT03184987Phase 3Completed

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Role: collaborator

NCT03815318Phase 3Completed

Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A

Role: collaborator

NCT03202004Phase 3Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Role: collaborator

All 15 trials loaded